Search

Displaying results 7721 - 7730 of 10000 in total
  1. Drug

    TSHA-118

    go.drugbank.com/drugs/DB16996
    Experimental

    TSHA-118 is a self-complementary AAV9 gene replacement therapy designed to express a human codon-optimized CLN1 transgene for the treatment of CLN1 disease.

  2. Drug

    ACT-101

    go.drugbank.com/drugs/DB17000
    Experimental

    ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.

  3. Drug

    Indatraline

    go.drugbank.com/drugs/DB17032
    Experimental

    Indatraline is a nonselective monoamine reuptake inhibitor.[A253022]

  4. Drug

    Dacinostat

    go.drugbank.com/drugs/DB17034
    Experimental

    Dacinostat is a novel histone deacetylase inhibitor.[A253032]

  5. Drug

    SB 224289

    go.drugbank.com/drugs/DB17052
    Experimental

    SB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.[A253122]

  6. Drug

    Spiperone

    go.drugbank.com/drugs/DB17056
    Experimental

    Spiperone is a dopamine antagonist that binds dopamine and serotonin receptors.[A253142]

  7. Drug

    TW-37

    go.drugbank.com/drugs/DB17059
    Experimental

    TW-37 is a small-molecule inhibitor of Bcl-2 investigated for its anti-cancer properties.[A253157]

  8. Drug

    U-0126

    go.drugbank.com/drugs/DB17060
    Experimental

    U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and MEK-2.[A253162]

  9. Drug

    ZM-39923

    go.drugbank.com/drugs/DB17064
    Experimental

    ZM-39923 is a small molecule that inhibits Janus kinase and human tissue transglutaminase (TGM2).[A253177]

    Synonyms: Jak3 inhibitor iv
  10. Drug

    Autologous Hematopoietic Peripheral Blood Stem Cells

    go.drugbank.com/drugs/DB17067
    Investigational

    Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by Northwestern University for the treatment of refractory myasthenia gravis.